Prof. Wei Chong | Oncology | Best Researcher Award

Professor at Shandong Provincial Hospital China

Professional Profiles

🎓 Educational Background

Dr. Chong Wei has pursued a distinguished academic journey in the field of oncology and gastrointestinal research. She earned her Bachelor’s degree in Biotechnology from Shandong Second Medical University (2011-2015). She then obtained a Doctoral degree in Oncology from Tianjin Medical University Cancer Hospital (2015-2020), where she focused on cancer research and treatment strategies. Further advancing her expertise, she completed her Postdoctoral research in Surgery at Shandong Provincial Hospital (2021-2023), specializing in multi-omics molecular typing and precision treatment of digestive tract tumors.

🏥 Professional Experience

Dr. Chong Wei has made significant contributions to medical research and education. She began her career as a Research Assistant in the Department of Gastrointestinal Surgery at Shandong First Medical University Affiliated Provincial Hospital (2020-2022). She later became an Associate Professor at the Medical Science and Technology Innovation Center of Shandong First Medical University (2020-2025). Currently, she serves as a Postdoctoral Supervisor (since 2021) and Master’s Advisor (since 2022) in the Department of Gastrointestinal Surgery. Additionally, she holds the position of Deputy Director at the Laboratory of Basic and Clinical Oncology of Digestive Tract (since 2022).

🏆 Awards in Scientific and Technological Achievements

Dr. Chong Wei’s groundbreaking research has earned her multiple prestigious awards:

Shandong Province Science and Technology Progress Award (Second Prize, 2021) – For establishing a diagnostic and treatment system for colorectal cancer based on molecular markers and tumor microenvironment characteristics.

Third Prize of Youth Science and Technology Award (2023) – Recognized by the Shandong Medical Association for her work on tumor markers and precision diagnosis of digestive tract tumors.

First Prize of Science and Technology Award (2023) – Awarded by the Shandong Medical Engineering Society for her development of an automatic monitoring system for digestive tract tumor markers.

🏅 Honors & Recognitions

Dr. Chong Wei has received several prestigious accolades for her contributions to cancer research:

Excellence Award (2022) – Presented at the 17th National Gastric Cancer Academic Conference as part of the Gastric Cancer Future Scientist Award.

Third Prize (2024) – Received at the 18th National Gastric Cancer Academic Conference for her continued research on gastric cancer advancements.

Outstanding Poster Award (2022) – Honored by the Medical Science and Technology Innovation Center for presenting innovative research findings.

🔬 Research Focus & Impact

Dr. Chong Wei’s research centers on multi-omics molecular typing and precision medicine for digestive tract tumors. Her work aims to revolutionize cancer diagnosis and treatment through advanced molecular analysis and targeted therapeutic approaches. She has played a key role in developing tumor biomarker screening techniques that enhance the early detection and personalized treatment of gastrointestinal cancers.

👩‍🏫 Contributions to Medical Science & Education

Beyond her research, Dr. Chong Wei is committed to mentoring young scientists and medical professionals. As a Postdoctoral Supervisor and Master’s Advisor, she guides researchers in oncology and gastrointestinal studies, fostering innovation in clinical and laboratory research.

Noted Publications📝

Article: Mechanisms and therapeutic potential of the hedgehog signaling pathway in cancer

Authors: Ge Cong, Xingyu Zhu, Xin Ru Chen, Hao Chen, Wei Chong
Journal: Cell Death Discovery
Year: 2025

Article: Molecular characterization and clinical relevance of metabolic signature subtypes in gastric cancer

Authors: Chen H, Jing C, Shang L, Zhu X, Zhang R, Liu Y, Wang M, Xu K, Ma T, Jing H et al.
Journal: Cell Reports
Year: 2024

Article: Clinical features and molecular landscape of cuproptosis signature‐related molecular subtype in gastric cancer

Authors: Wei Chong, Huicheng Ren, Hao Chen, Kang Xu, Xingyu Zhu, Yuan Liu, Yaodong Sang, Han Li, Jin Liu, Chunshui Ye et al.
Journal: iMeta
Year: 2024

Article: Research progress of exosomes in the angiogenesis of digestive system tumour

Authors: Yuan Liu, Hao Wu, Yaodong Sang, Wei Chong, Liang Shang, Leping Li
Journal: Discover Oncology
Year: 2024

Article: Phospholysine phosphohistidine inorganic pyrophosphate phosphatase suppresses insulin-like growth factor 1 receptor expression to inhibit cell adhesion and proliferation in gastric cancer

Authors: Zhang Z, Wang X, Liu Y, Wu H, Zhu X, Ye C, Ren H, Chong W, Shang L, Li L
Journal: MedComm
Year: 2024

🎓Educational Background

Mahmoud Mohamed Alfishawy is currently a PhD candidate in the Biophysics Department at Al-Azhar University, Cairo, Egypt, since March 2021. He completed his Master of Biophysics at Ain Shams University, Cairo, Egypt, in September 2019, and holds a Diploma of Radiation Physics from the same university, awarded in September 2007. He earned his Bachelor of Science in Biophysics from Al-Azhar University, Cairo, Egypt, in May 2005.

💼Employment History

Mahmoud has extensive experience in medical physics, particularly in radiation oncology. He currently serves as a Senior Medical Physicist at the Sultan Qaboos Comprehensive Cancer Center, a JCI-accredited hospital, where he has been employed since April 2021. Prior to this role, he worked at the International Medical Center (also JCI-accredited) from April 2008 to April 2021 as a Senior Medical Physicist. Mahmoud has also worked in various other prestigious hospitals, including Wadi El-Neel Hospital and As-Salam International Hospital, holding senior roles from January 2010 to April 2021. He began his career at Al-Hussein Hospital as a Medical Physicist from January 2006 to March 2008.

🔬Clinical Experience

Mahmoud’s clinical expertise spans a wide range of radiation therapy machines, including CyberKnife, TrueBeam, Versa HD, Clinac, Cobalt 60, and others. He is experienced with advanced dosimetry systems, such as PTW and Sunnuclear, and patient-specific QA systems like Octavius 4D, Sunnuclear SRS Mapcheck, and Portal Dosimetry. His proficiency in radiation therapy techniques includes 3DCRT, IMRT, VMAT, IGRT, SRS, and SBRT, and he is adept at using treatment planning systems like Accuray Precision and Eclipse.

🏆Awards

Mahmoud has received numerous accolades for his contributions to radiation therapy and dosimetry. Notably, he was a co-author of the MESTRO 2023 First Award for his abstract on In-Vivo Dosimetry using Diodes and Mosfets in Radiation Therapy. He also won the Proknow PSCO Plan Study 2024 First Award for a Head and Neck Case. Furthermore, he received two awards in the Arabian Radiotherapy Plan Competition 2019: First Award for 3DCRT and HYBRID (Craniospinal case) and Second Award for VMAT (Craniospinal case).

Publications Top Noted📝

Impact of flattening filter-free beams on remaining volume at risk in lung cancer treatment

Authors: Alfishawy, M.M., Kany, A.I., Elshahat, K.M.

Journal: Radiation and Environmental Biophysics

Year: 2024

Stereotactic radiotherapy: An educational narrative review

Authors: Khan, A.M.H., Hashmi, S.F.A., Li, B., Rassou, S.C., Mula-Hussain, L.

Journal: Precision Radiation Oncology

Year: 2024